For Physicians

Introduction by Robert Kyle, MD

It is an honor and a pleasure to provide an introductory note to this issue of Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC)'s "Advances in Hematologic Malignancies," with a focus on multiple myeloma.

Complex Case Study: Multiple Myeloma with Secondary Light Chain Amyloidosis

A 59-year-old woman presented with three months of fatigue and severe joint pain involving the elbows, wrists, knees, and ankles, as well as anemia. She underwent a total of four diagnostic arthrocenteses, though the specific underlying cause of joint pain remained unknown.

Research Spotlight: Bench to Bedside Translation of Targeted Therapeutics in Multiple Myeloma

Multiple myeloma (MM) is a remarkable contemporary example of rapid bench-to-bedside translation in new drug development.

Patient Care Spotlight: Current Management of Hypercalcemia Associated with Multiple Myeloma

Patients with multiple myeloma are commonly diagnosed with hypercalcemia.

New DF/BWCC Program Physician in Waldenström's Macroglobulinemia

The Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC) Bing Center for Waldenström's Macroglobulinemia is pleased to welcome Jorge Castillo, MD, as program physician.

Hematologic Malignancies: Physician Resources

If you are a clinician specializing in the field of hematologic oncology, we can help you refer a patient, explore open clinical trials, learn about CME events, and more.

View our full list of hematologic malignancies resources for referring providers.